Consequently, hyperactivity of CLK2 kinase on CFIm68/59 as seen in several cancer cell lines prevents CFIm activity, as well as its nuclear local concentration into liquid–liquid phase separation foci – possibly by affecting its ability to interact with other SR proteins and CPSF.158, 53, 100. The gene discussed is CLK2; the disease is cancer.